{"gene":"NR0B1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1997,"finding":"DAX-1 binds DNA hairpin structures and acts as a transcriptional repressor of the StAR (steroidogenic acute regulatory protein) gene promoter, blocking steroid production in vitro and in vivo. DAX-1 binding sites were identified in the promoters of the dax-1 and StAR genes.","method":"In vitro DNA binding assays, transcriptional reporter assays (in vitro and in vivo), promoter analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro and in vivo assays with specific DNA binding and transcriptional repression demonstrated in multiple systems","pmids":["9384387"],"is_preprint":false},{"year":1998,"finding":"DAX-1 blocks steroid production at multiple levels by repressing StAR, P450scc, and 3beta-HSD promoter activities in adrenocortical Y-1 cells, impairing both basal and cAMP-stimulated steroid production without affecting the PKA pathway.","method":"Cell line expression (Y-1 cells), steroid production assays, promoter activity assays, cAMP pathway analysis","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple target genes tested with promoter assays and functional steroid production measurements in a defined cell system","pmids":["9751505"],"is_preprint":false},{"year":1998,"finding":"Dax1 antagonizes Sry action in mammalian sex determination; XY mice carrying extra copies of Dax1 show delayed testis development, and sex reversal occurs when the transgene is tested against weak Sry alleles, establishing a dosage-sensitive genetic epistasis between Dax1 and Sry.","method":"Transgenic mouse overexpression, genetic epistasis with weak Sry alleles","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis in transgenic mouse model with defined allelic combinations, replicated across multiple Sry backgrounds","pmids":["9486644"],"is_preprint":false},{"year":1998,"finding":"Loss of Ahch/Dax1 in male mice causes progressive degeneration of the testicular germinal epithelium and male sterility independent of abnormalities in gonadotropin and testosterone production, establishing Dax1 as essential for spermatogenesis maintenance. Female Ahch-null mice have normal ovarian development and fertility.","method":"Cre-mediated conditional gene knockout in mice, histological analysis, hormone measurement","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean loss-of-function mouse model with specific phenotypic readout and hormonal controls","pmids":["9843206"],"is_preprint":false},{"year":2000,"finding":"DAX-1 protein is found both in the nucleus and cytoplasm; a significant proportion associates with polyribosomes and binds polyadenylated RNA. Two domains within DAX-1 mediate cooperative RNA binding. AHC-causing mutations significantly impair RNA binding, suggesting a post-transcriptional regulatory role.","method":"Subcellular fractionation, polyribosome sedimentation, RNA binding assays (direct), mutational analysis of AHC alleles","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct RNA binding demonstrated in vitro, subcellular fractionation, and mutational analysis linking RNA binding to disease; single lab but multiple orthogonal methods","pmids":["10848616"],"is_preprint":false},{"year":2001,"finding":"AHC-associated DAX1 missense mutations abrogate its ability to act as a transcriptional repressor of SF-1, as demonstrated in transfection assays. All missense mutations are located within the carboxy-terminal half of the protein (putative ligand binding domain).","method":"Transfection reporter assays, mutational analysis of patient-derived alleles","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transfection assays with multiple disease mutations, single lab","pmids":["11738790"],"is_preprint":false},{"year":2001,"finding":"Sertoli cell-specific expression of a human DAX1 transgene (MIS promoter) partially rescued fertility in Dax1-deficient male mice, restoring sperm motility, epididymal sperm count, and in vitro fertilization capacity, establishing that Dax1 function in Sertoli cells is sufficient to overcome key thresholds for sperm production.","method":"Transgenic rescue in Dax1-knockout mice with cell type-specific promoter, fertility assays, sperm function assays","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific transgenic rescue with multiple functional readouts in defined genetic background","pmids":["11356697"],"is_preprint":false},{"year":2002,"finding":"DAX-1 inhibits cAMP/SF-1-mediated aromatase P450 (P450arom) promoter activity in a dose-dependent manner in cultured human endometriotic and endometrial stromal cells; site-directed disruption of the SF-1 binding site in the P450arom promoter abolishes this effect, indicating DAX-1 acts through the SF-1 binding site.","method":"Transient transfection reporter assays, site-directed mutagenesis of promoter, human primary cell cultures","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with mutagenesis in primary human cells, single lab","pmids":["12213901"],"is_preprint":false},{"year":2002,"finding":"Dax1 expression in the developing gonad is regulated by steroidogenic factor 1 (SF-1) via a conserved SF-1 consensus-binding site located ~4 kb upstream of the Dax1 start codon; Dax1 expression is greatly reduced in SF-1-deficient gonads.","method":"Transgenic reporter (LacZ) mouse assay, site-directed mutagenesis of SF-1 binding site, analysis of SF-1-null embryos","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic reporter with binding site mutagenesis and genetic knockout validation","pmids":["11923472"],"is_preprint":false},{"year":2003,"finding":"Leydig cell-specific expression of DAX1 (LHR promoter transgene) in Dax1-knockout mice restores aromatase expression to normal levels and increases sperm production, establishing that Dax1 function in Leydig cells contributes to testicular function and that Dax1 deficiency in Leydig cells underlies aromatase overexpression.","method":"Transgenic rescue with Leydig cell-specific promoter in Dax1-knockout background, aromatase expression analysis, sperm counting","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific transgenic rescue with defined molecular and phenotypic endpoints","pmids":["12606353"],"is_preprint":false},{"year":2003,"finding":"Nr0b1/Dax1 is required for testis differentiation; loss of Nr0b1 in mice impairs rather than promotes testis formation, contradicting the earlier 'anti-testis' model and instead supporting a pro-testis role.","method":"Targeted gene knockout in mice, gonadal development analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean loss-of-function mouse model with definitive developmental phenotype","pmids":["12679814"],"is_preprint":false},{"year":2005,"finding":"In the developing testis, Sf1 and Dax1 function cooperatively (not antagonistically) to induce Dhh and Amh expression in Sertoli cells; double mutant Sf1/Dax1 gonads show reduced Dhh undetectable by E11.5, more severe than either single mutant, while Cyp17 and Cyp11a1 (fetal Leydig markers) are further reduced in double mutants compared to Sf1 heterozygotes alone.","method":"Genetic epistasis using compound mutant mice (Sf1 heterozygous × Dax1-null), gene expression analysis at defined embryonic stages","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — well-controlled genetic epistasis with multiple gene expression readouts at multiple time points","pmids":["15829514"],"is_preprint":false},{"year":2006,"finding":"NR0B1 expression is required for the oncogenic/transformed phenotype of Ewing's sarcoma cells; retroviral-mediated RNAi knockdown of NR0B1 in patient-derived Ewing's sarcoma cell lines abolishes the transformed phenotype. NR0B1 is the most reproducibly upregulated EWS/FLI target gene across three Ewing's sarcoma lines.","method":"Retroviral RNAi knockdown in patient-derived cell lines, transcriptional profiling, functional transformation assays","journal":"Molecular cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi knockdown with functional oncogenic phenotype readout in three independent patient-derived cell lines","pmids":["17114343"],"is_preprint":false},{"year":2006,"finding":"DAX1 (NR0B1) is specifically upregulated by the EWS/FLI1 fusion oncoprotein (not by wild-type FLI1) in 293 cells and Ewing tumor cells; siRNA silencing of EWS/FLI1 in a Ewing cell line markedly reduces DAX1 mRNA and protein, confirming direct dependence on EWS/FLI1.","method":"cDNA arrays with inducible EWS/FLI1 expression, RNAi silencing, RT-PCR, immunoblot","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible expression and RNAi knockdown in two independent cell systems, confirmed at mRNA and protein level","pmids":["16206264"],"is_preprint":false},{"year":2006,"finding":"Zebrafish dax1 functions downstream of ff1b (SF-1) in regulating the interrenal organ (adrenal cortex equivalent); dax1 morpholino knockdown downregulates steroidogenic genes cyp11a and star, and ff1b morpholino abolishes dax1 expression in the interrenal organ, while dax1 morpholino does not affect ff1b expression.","method":"Morpholino oligonucleotide knockdown in zebrafish, whole-mount in situ hybridization, gene expression analysis","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via morpholino in zebrafish with defined expression readouts, single lab","pmids":["16840536"],"is_preprint":false},{"year":2006,"finding":"DAX1 forms homodimers in both nucleus and cytoplasm; homodimerization involves an interaction between DAX1 amino and carboxy termini through LXXLL motifs and the AF-2 domain. DAX1 homodimers dissociate upon heterodimerization with SF-1 or ligand-activated ERα. DAX1-SHP heterodimers also form in the nucleus via LXXLL motifs and AF-2 domain.","method":"Co-immunoprecipitation in mammalian cells, subcellular localization studies, domain-deletion and mutagenesis analysis","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mutagenesis, single lab, multiple orthogonal approaches","pmids":["16709599"],"is_preprint":false},{"year":2006,"finding":"Dax1 has a novel role in maintaining a relatively undifferentiated state in early embryogenesis; siRNA knockdown of Nr0b1 in embryonic stem cells causes differentiation toward endoderm-like fate, and conditional knockout of Nr0b1 in ES cells leads to differentiation, indicating Nr0b1 maintains pluripotency independent of steroidogenesis.","method":"siRNA knockdown in ES cells, Cre-mediated conditional knockout in ES cells, differentiation assays","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown and knockout with differentiation readouts, single lab, two orthogonal loss-of-function approaches","pmids":["16466956"],"is_preprint":false},{"year":2009,"finding":"Dax-1 can function as a dosage-dependent coactivator of SF-1 target genes (rather than solely as a repressor). Both SF-1 and Dax-1 bind the RNA coactivator SRA; TIF2 associates with Dax-1 and synergistically coactivates SF-1 targets. Knockdown of endogenous Dax-1 downregulates CYP11A1 and StAR expression in adrenal and Leydig cells. A naturally occurring Dax-1 mutation inhibits this coactivation and mislocalizes the Dax-1/TIF2 complex.","method":"Co-immunoprecipitation, luciferase reporter assays, siRNA knockdown of SRA and Dax-1, live-cell imaging of protein localization, patient mutation analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, reporter, RNAi, localization) in multiple cell types with disease mutation validation","pmids":["19188450"],"is_preprint":false},{"year":2009,"finding":"NR0B1 and EWS/FLI physically interact; this protein-protein interaction is required for oncogenic transformation of Ewing's sarcoma cells. NR0B1 mutations that disrupt the interaction have transcriptional consequences and abrogate oncogenic transformation. Genome-wide ChIP shows NR0B1 and EWS/FLI co-localize at overlapping genomic targets.","method":"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), transcriptional profiling, transformation assays with NR0B1 interaction-defective mutants","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, ChIP-seq co-localization, and functional mutant rescue across multiple endpoints","pmids":["19920188"],"is_preprint":false},{"year":2009,"finding":"DAX1 (NR0B1) is expressed in cancer stem cell-enriched side population of lung adenocarcinoma; NR0B1 knockdown reduces invasion, colony formation, and tumorigenicity in NOD/SCID mice, establishing a functional role in lung adenocarcinoma malignancy.","method":"Hoechst dye exclusion (side population assay), RNAi knockdown, in vitro invasion and colony assays, xenograft tumorigenicity assay","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown with multiple functional oncogenic readouts including in vivo xenograft, single lab","pmids":["19644015"],"is_preprint":false},{"year":2010,"finding":"In mouse ES cells, Dax1 forms a complex with LRH-1 (Nr5a2) demonstrated by co-immunoprecipitation. Contrary to its repressor role in steroidogenic cells, Dax1 accentuates LRH-1-mediated activation of the Oct4 gene; Dax1 is localized to the Oct4 promoter at the LRH-1 binding site by ChIP. This coactivation is dependent on the RNA coactivator SRA.","method":"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), luciferase reporter assays with Dax1 overexpression/knockdown, SRA knockdown","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, ChIP, reporter, RNAi) in mES cells establishing coactivation mechanism","pmids":["20943815"],"is_preprint":false},{"year":2010,"finding":"LRH-1 binds the -128 site of the Dax1 promoter to regulate its expression in mouse ES cells; Nanog binds an intronic site of Dax1 and enhances transcription. Overexpression and knockdown of both LRH-1 and Nanog alter Dax1 expression, establishing cooperative transcriptional regulation of Dax1 in ES cells.","method":"Luciferase reporter assays, EMSA, chromatin immunoprecipitation, overexpression and knockdown experiments","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (EMSA, ChIP, reporter, OE/KD) in a single lab","pmids":["20937355"],"is_preprint":false},{"year":2013,"finding":"Dax1 interacts with the orphan nuclear receptor Esrrb through DAX1 LXXLL motifs and Esrrb activation/ligand-binding domains. Dax1 represses Esrrb transcriptional activity. Esrrb also directly binds the Dax1 promoter (ERRE1 site) to enhance Dax1 expression in an Oct3/4-independent manner. Oct3/4, Dax1, and Esrrb exhibit competitive inhibitory interactions forming a regulatory loop.","method":"Co-immunoprecipitation, luciferase reporter assays, EMSA/direct binding assays, overexpression and knockdown in ES cells","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mapping and reporter assays, single lab","pmids":["23508100"],"is_preprint":false},{"year":2014,"finding":"Dax1 acts in parallel with Nanog to maintain mouse ES cell identity; Dax1 overexpression supports LIF-independent self-renewal; Dax1 stable knockdown predisposes mESCs towards differentiation. Dax1 is indispensable for self-renewal of Nanog-low mESCs. Dax1 prevents extra-embryonic endoderm commitment by directly repressing Gata6 transcription.","method":"Stable knockdown, overexpression, inducible knockdown, LIF-withdrawal assay, luciferase/reporter assays for Gata6 repression, reprogramming assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple loss-of-function and gain-of-function approaches with specific cellular and molecular readouts; direct promoter repression shown","pmids":["25284313"],"is_preprint":false},{"year":2015,"finding":"Nr0b1 (Dax1)-null mouse ES cells are viable and pluripotent but exhibit slow proliferation and overexpression of 2-cell-stage transcripts including Zscan4c. Nr0b1 directly represses the Zscan4c promoter; overexpression of Zscan4c causes G2 arrest and cell death, explaining the proliferation defect.","method":"Inducible Cre-loxP knockout in ES cells, chimera assay for pluripotency, transcriptome analysis, direct promoter repression assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible knockout with defined molecular mechanism (direct promoter repression), single lab","pmids":["25772165"],"is_preprint":false},{"year":2016,"finding":"nr0b1 mutation in zebrafish causes female-to-male sex reversal through reduced cell proliferation and abnormal somatic cell differentiation in gonads at the undifferentiated and bi-potential ovary stages, without increasing apoptosis (Caspase-3, tp53-independent mechanism).","method":"CRISPR/ENU-generated heritable nr0b1 mutations in zebrafish, histological analysis, cell proliferation assays, genetic epistasis with tp53 mutation","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — heritable loss-of-function with cellular mechanism defined, genetic epistasis performed, single lab","pmids":["27267667"],"is_preprint":false},{"year":2017,"finding":"Sf1 SUMOylation enhances binding of Dax1 to Sf1, which further enhances transcriptional repression of the fetal adrenal enhancer (FAdE). In vivo, both SUMOylation-deficient Sf1 and Dax1-knockout mice show delayed regression of the postnatal fetal adrenal cortex (X-zone), with FAdE expression retained in postnatal X-zone cells.","method":"In vitro binding assays, transgenic reporter mouse models (FAdE-LacZ), Sf1 SUMOylation-deficient knock-in mice, Dax1-knockout mice","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro binding assay with multiple in vivo mouse models demonstrating convergent repressor function","pmids":["28893949"],"is_preprint":false},{"year":2018,"finding":"DAX1 promotes cervical cancer cell growth and tumorigenicity by transcriptionally repressing GSK3β (an inhibitor of Wnt/β-catenin) through direct binding to the -666~-444 region of the GSK3β promoter, as confirmed by dual-luciferase reporter and ChIP assays, leading to activation of Wnt/β-catenin signaling and upregulation of cyclinD1 and c-myc.","method":"RNAi knockdown, TOP/FOP-Flash Wnt reporter assay, ChIP assay, dual-luciferase reporter assay, GSK3β pharmacological rescue","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays define direct promoter binding, functional rescue confirms mechanism, single lab","pmids":["29497051"],"is_preprint":false},{"year":2022,"finding":"TRIM66 recruits DAX1 as a co-repressor to the Dux promoter to suppress the totipotent 2-cell-like state in mESCs. TRIM66's repressive effect on Dux is dependent on DAX1. Crystal structure shows TRIM66's PHD finger recognizes H3K4-K9me3; mutations in the PHD finger abolish Dux repression.","method":"Co-IP, ChIP, crystal structure determination, mutagenesis of PHD finger, chimeric embryo assays, Dux reporter assays","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with co-IP, ChIP, and functional mutagenesis in a single rigorous study","pmids":["35659877"],"is_preprint":false},{"year":2006,"finding":"A missense mutation in the hinge region of DAX1 (C200W) shifts subcellular localization from nucleus to cytoplasm and impairs transcriptional repression activity. Nuclear import of DAX1 involves a direct interaction with SF-1; the C200W mutant retains ability to interact with SF-1 in vitro, suggesting SF-1-independent interactions are responsible for the import defect.","method":"Immunohistochemistry of transfected cells, transcriptional repression assays, in vitro interaction assays","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — subcellular localization tied to functional repression defect, in vitro interaction assay, single lab","pmids":["16459121"],"is_preprint":false},{"year":2009,"finding":"Retinoic acid (RA)-induced nNOS transcription in human neuroblastoma TGW-nu-I cells requires DAX1 (NR0B1) as a critical mediator; RA increases DAX1 expression via PI3K/Akt signaling, and upregulation of DAX1 in turn induces nNOS transcription. DAX1 knockdown blocks RA-induced nNOS expression, identifying nNOS as a DAX1 target gene in this pathway.","method":"Pharmacological inhibition of PI3K/Akt, DAX1 overexpression and knockdown, transcriptional reporter/RT-PCR assays in human neuroblastoma cells","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown and overexpression with pathway inhibitors in a defined cellular context, single lab","pmids":["19726747"],"is_preprint":false},{"year":2007,"finding":"LXXLL motifs and AF-2 domain of SHP mediate SHP homodimerization and DAX1-SHP heterodimerization. DAX1 LXXLL motifs are redundant for DAX1 homodimerization. DAX1A (alternatively spliced isoform) localizes predominantly to cytoplasm but forms DAX1-DAX1A heterodimers in the nucleus, with AF-2 domain of DAX1 required for this interaction.","method":"Co-immunoprecipitation, domain deletion and mutagenesis, subcellular localization analysis","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mutagenesis, single lab, extends prior homodimerization findings","pmids":["17686645"],"is_preprint":false}],"current_model":"NR0B1/DAX1 is an atypical orphan nuclear receptor that functions context-dependently as a transcriptional repressor or coactivator: it represses steroidogenic gene promoters (StAR, P450scc, 3β-HSD, aromatase) by binding DNA hairpin structures and/or inhibiting SF-1/LRH-1-mediated transactivation, forms homo- and heterodimers (with SHP, DAX1A) via LXXLL motifs and an AF-2 domain, shuttles between nucleus and cytoplasm where it also binds polyribosomal mRNA, and can coactivate SF-1/LRH-1 target genes (including Oct4) through the RNA coactivator SRA and TIF2; in ES cells it directly represses Gata6 and Zscan4c to maintain pluripotency, and in Ewing's sarcoma it physically interacts with the EWS/FLI oncoprotein to co-regulate transcription and drive oncogenic transformation."},"narrative":{"mechanistic_narrative":"NR0B1/DAX1 is an atypical orphan nuclear receptor that operates as a context-dependent transcriptional regulator coordinating steroidogenesis, gonadal development, and stem cell pluripotency [PMID:9384387, PMID:16466956]. In steroidogenic tissues it represses the promoters of StAR, P450scc, 3beta-HSD, and aromatase, blocking both basal and cAMP-stimulated steroid output, largely by binding DNA hairpin structures and antagonizing SF-1 at SF-1 response elements [PMID:9384387, PMID:9751505, PMID:12213901]; this repressor function is abolished by AHC-associated missense mutations clustered in the carboxy-terminal ligand-binding domain [PMID:11738790]. DAX1 self-associates and partners with other receptors—forming homodimers and DAX1-SHP and DAX1-DAX1A heterodimers through its LXXLL motifs and AF-2 domain, with homodimers dissociating upon engagement of SF-1 or ligand-activated ERalpha [PMID:16709599, PMID:17686645]. Rather than acting purely as a repressor, DAX1 can also coactivate SF-1 and LRH-1 target genes through the RNA coactivator SRA and the cofactor TIF2, and its own expression is reciprocally driven by SF-1, LRH-1, Nanog, and Esrrb [PMID:19188450, PMID:20943815, PMID:11923472, PMID:20937355]. DAX1 expression and activity are tightly dosage-sensitive in gonadal development: it cooperates with SF-1 to induce Sertoli-cell genes (Dhh, Amh) and is required in both Sertoli and Leydig cells for spermatogenesis and proper aromatase control [PMID:15829514, PMID:11356697, PMID:12606353], and its loss impairs testis differentiation [PMID:12679814]. In embryonic stem cells DAX1 maintains pluripotency independently of steroidogenesis by directly repressing the endoderm regulator Gata6 and the 2-cell-stage gene Zscan4c, and it serves as a TRIM66-recruited co-repressor of Dux to suppress the totipotent 2-cell-like state [PMID:25284313, PMID:25772165, PMID:35659877]. DAX1 also functions oncogenically: it is the most reproducible EWS/FLI1 target in Ewing's sarcoma, where a direct NR0B1–EWS/FLI protein interaction is required for transformation and co-occupies overlapping genomic targets [PMID:16206264, PMID:17114343, PMID:19920188]. A significant pool of DAX1 resides in the cytoplasm associated with polyribosomes and polyadenylated RNA, a post-transcriptional activity also impaired by AHC mutations [PMID:10848616].","teleology":[{"year":1997,"claim":"Established the core molecular activity of DAX1 by showing it is a sequence-specific transcriptional repressor of steroidogenic genes, defining its biochemical identity beyond an orphan receptor.","evidence":"In vitro DNA binding and reporter assays on the StAR and dax-1 promoters","pmids":["9384387"],"confidence":"High","gaps":["DNA hairpin recognition not structurally resolved","no endogenous genome-wide binding map"]},{"year":1998,"claim":"Defined the breadth of DAX1's anti-steroidogenic action and its dosage-sensitive antagonism of male sex determination, framing DAX1 as a brake on steroid output and an 'anti-testis' factor.","evidence":"Promoter and steroid-production assays in Y-1 cells; transgenic mouse epistasis against weak Sry alleles","pmids":["9751505","9486644"],"confidence":"High","gaps":["repressor mechanism on multiple promoters not distinguished (direct DNA vs SF-1 antagonism)","the anti-testis model later revised"]},{"year":1998,"claim":"Loss-of-function in mice revealed DAX1 is essential for spermatogenesis maintenance independent of hormonal output, separating a tissue role from its endocrine repressor function.","evidence":"Conditional knockout in mice with histology and hormone measurement","pmids":["9843206"],"confidence":"High","gaps":["cell type responsible not yet localized","molecular targets in germinal epithelium unknown"]},{"year":2000,"claim":"Discovered a non-transcriptional facet of DAX1—cytoplasmic polyribosome and RNA binding—linking it to post-transcriptional regulation and tying this activity to disease alleles.","evidence":"Subcellular fractionation, polyribosome sedimentation, direct RNA binding and AHC mutant analysis","pmids":["10848616"],"confidence":"High","gaps":["specific mRNA targets not identified","physiological consequence of RNA binding unresolved"]},{"year":2001,"claim":"Connected AHC-causing missense mutations to loss of SF-1 repression and mapped them to the C-terminal LBD, establishing a genotype-to-mechanism link for the disease.","evidence":"Transfection reporter assays of patient-derived alleles","pmids":["11738790"],"confidence":"Medium","gaps":["single-lab transfection data","no structural basis for LBD mutation effects"]},{"year":2001,"claim":"Cell-type-specific transgenic rescue localized a key reproductive function of DAX1 to Sertoli cells, refining where its activity is required.","evidence":"MIS-promoter human DAX1 transgene rescue in Dax1-null mice with fertility/sperm assays","pmids":["11356697"],"confidence":"High","gaps":["rescue only partial","molecular targets in Sertoli cells not defined"]},{"year":2002,"claim":"Showed DAX1 represses aromatase via the SF-1 binding site and that SF-1 drives Dax1 expression, establishing a reciprocal SF-1/DAX1 regulatory relationship.","evidence":"Promoter mutagenesis/reporter assays in human stromal cells; transgenic LacZ reporter and SF-1-null embryo analysis","pmids":["12213901","11923472"],"confidence":"High","gaps":["whether repression requires direct DAX1-DNA contact or only SF-1 tethering unresolved"]},{"year":2003,"claim":"Genetic and rescue studies revised the sex-determination model, showing DAX1 promotes rather than opposes testis differentiation and acts in Leydig cells to control aromatase.","evidence":"Targeted knockout gonad analysis; LHR-promoter Leydig-specific transgenic rescue","pmids":["12679814","12606353"],"confidence":"High","gaps":["mechanistic reconciliation of dosage 'anti-testis' overexpression with loss-of-function pro-testis role incomplete"]},{"year":2005,"claim":"Compound-mutant epistasis demonstrated that DAX1 and SF-1 act cooperatively—not antagonistically—to induce Sertoli-cell genes, redefining their relationship in development.","evidence":"Sf1/Dax1 compound mutant mice with staged expression analysis of Dhh, Amh, Cyp17, Cyp11a1","pmids":["15829514"],"confidence":"High","gaps":["direct vs indirect cooperativity at target promoters not dissected"]},{"year":2006,"claim":"Defined the structural basis of DAX1 dimerization and identified its self- and partner-association via LXXLL/AF-2 modules, explaining how dimer state couples to SF-1/ER engagement.","evidence":"Co-IP, domain mutagenesis, and localization studies of DAX1 homodimers and DAX1-SHP and DAX1-DAX1A heterodimers","pmids":["16709599","17686645"],"confidence":"Medium","gaps":["single-lab co-IP without structure","functional output of each dimer species not separated"]},{"year":2006,"claim":"Revealed a steroidogenesis-independent role in maintaining the undifferentiated state of ES cells, expanding DAX1's biology into pluripotency.","evidence":"siRNA and conditional knockout in ES cells with differentiation assays","pmids":["16466956"],"confidence":"Medium","gaps":["direct target genes not yet identified at this stage","single-lab"]},{"year":2006,"claim":"Mapped a hinge-region mutation (C200W) that mislocalizes DAX1 to cytoplasm and abolishes repression, implicating SF-1-independent nuclear import in its activity.","evidence":"Immunohistochemistry, repression assays, and in vitro interaction assays of the C200W mutant","pmids":["16459121"],"confidence":"Medium","gaps":["the import factor responsible not identified","single-lab"]},{"year":2006,"claim":"Identified NR0B1 as a critical, reproducibly upregulated EWS/FLI1 target required for the transformed phenotype in Ewing's sarcoma, opening an oncogenic dimension.","evidence":"Inducible EWS/FLI1 expression, RNAi silencing, and transformation assays across multiple Ewing cell lines","pmids":["17114343","16206264"],"confidence":"High","gaps":["mechanism of NR0B1 contribution to transformation not yet defined at this stage"]},{"year":2006,"claim":"Cross-species work placed dax1 downstream of SF-1 (ff1b) in regulating the adrenal-equivalent interrenal organ and its steroidogenic genes.","evidence":"Morpholino knockdown and in situ hybridization in zebrafish","pmids":["16840536"],"confidence":"Medium","gaps":["morpholino specificity caveats","single-lab"]},{"year":2009,"claim":"Reframed DAX1 as a dosage-dependent coactivator, not just a repressor, by linking it to the RNA coactivator SRA and TIF2 to activate SF-1 targets.","evidence":"Co-IP, reporter assays, SRA/Dax-1 knockdown, live-cell imaging, and disease-mutation analysis in adrenal/Leydig cells","pmids":["19188450"],"confidence":"High","gaps":["determinants switching DAX1 between repressor and coactivator modes unresolved"]},{"year":2009,"claim":"Established a direct NR0B1–EWS/FLI protein interaction required for transformation and showed genome-wide co-occupancy, providing the mechanistic link for DAX1's oncogenic role.","evidence":"Co-IP, ChIP, transcriptional profiling, and interaction-defective mutant rescue in Ewing cells","pmids":["19920188"],"confidence":"High","gaps":["how the interaction reshapes EWS/FLI transcriptional output mechanistically not fully defined"]},{"year":2009,"claim":"Extended DAX1's oncogenic relevance beyond Ewing's sarcoma to lung adenocarcinoma cancer-stem-cell function and to a neuronal RA/PI3K-Akt-nNOS axis, indicating broad context-specific roles.","evidence":"Side-population assay, RNAi, invasion/colony/xenograft assays in lung adenocarcinoma; pathway inhibition and knockdown/overexpression in neuroblastoma","pmids":["19644015","19726747"],"confidence":"Medium","gaps":["direct DAX1 targets in these contexts incompletely defined","single-lab each"]},{"year":2010,"claim":"Demonstrated context-switched coactivation in ES cells, where DAX1 complexes with LRH-1 to activate Oct4 via SRA, and that LRH-1/Nanog reciprocally drive Dax1, embedding it in the pluripotency network.","evidence":"Co-IP, ChIP, EMSA, reporter assays, and SRA/factor knockdown in mouse ES cells","pmids":["20943815","20937355"],"confidence":"High","gaps":["what dictates LRH-1 coactivation vs SF-1 repression unresolved"]},{"year":2013,"claim":"Positioned DAX1 within a competitive regulatory loop with Esrrb and Oct3/4, repressing Esrrb activity while being reciprocally regulated, refining pluripotency circuit logic.","evidence":"Co-IP with domain mapping, EMSA, reporter assays, and OE/KD in ES cells","pmids":["23508100"],"confidence":"Medium","gaps":["single-lab","in vivo relevance of the loop not tested"]},{"year":2014,"claim":"Defined a direct molecular mechanism for pluripotency maintenance—DAX1 represses Gata6 to block extra-embryonic endoderm—acting in parallel with Nanog.","evidence":"Stable/inducible knockdown, overexpression, LIF-withdrawal, Gata6 reporter, and reprogramming assays","pmids":["25284313"],"confidence":"High","gaps":["genome-wide direct target set not fully enumerated"]},{"year":2015,"claim":"Identified Zscan4c as a direct DAX1-repressed 2-cell-stage gene whose derepression causes proliferation defects, linking DAX1 to control of the totipotency program.","evidence":"Inducible knockout in ES cells, transcriptome analysis, and direct promoter repression assay","pmids":["25772165"],"confidence":"Medium","gaps":["single-lab","relationship to other 2C regulators not fully mapped"]},{"year":2017,"claim":"Showed SF-1 SUMOylation enhances DAX1 recruitment to drive repression of the fetal adrenal enhancer, providing a PTM-controlled mechanism for fetal adrenal X-zone regression.","evidence":"In vitro binding, FAdE-LacZ reporter mice, SUMO-deficient Sf1 knock-in and Dax1-knockout mice","pmids":["28893949"],"confidence":"High","gaps":["how SUMOylation alters the SF-1/DAX1 interface structurally unknown"]},{"year":2018,"claim":"Demonstrated a pro-oncogenic mechanism in cervical cancer where DAX1 directly represses GSK3beta to activate Wnt/beta-catenin signaling, expanding its tumor-promoting repertoire.","evidence":"RNAi, TOP/FOP-Flash Wnt reporter, ChIP, dual-luciferase, and GSK3beta rescue","pmids":["29497051"],"confidence":"Medium","gaps":["single-lab","in vivo confirmation limited"]},{"year":2022,"claim":"Provided structural and functional mechanism for DAX1 as a TRIM66-recruited co-repressor of Dux, showing how it suppresses the totipotent 2-cell-like state via a chromatin-reading module.","evidence":"Co-IP, ChIP, crystal structure of TRIM66 PHD finger, PHD mutagenesis, and chimeric embryo/Dux reporter assays","pmids":["35659877"],"confidence":"High","gaps":["DAX1's own contribution to repressive complex assembly not structurally resolved"]},{"year":null,"claim":"The molecular determinant that switches DAX1 between transcriptional repressor and coactivator across steroidogenic, pluripotency, and oncogenic contexts remains undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["no structural model of DAX1 DNA/hairpin or coactivator binding","the natural ligand (if any) and its role in mode-switching unknown","no unified rule predicting repressor vs coactivator output by partner/context"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,7,17,20,23,24,27]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,24,27]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[17,20,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,15,29]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,15,29,31]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,7,17,20,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,3,10,11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[12,18,19,27]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,7]}],"complexes":[],"partners":["NR5A1","NR5A2","NR0B2","ESRRB","EWSR1-FLI1","TIF2","TRIM66"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51843","full_name":"Nuclear receptor subfamily 0 group B member 1","aliases":["DSS-AHC critical region on the X chromosome protein 1","Nuclear receptor DAX-1"],"length_aa":470,"mass_kda":51.7,"function":"Nuclear receptor that lacks a DNA-binding domain and acts as a corepressor that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions (PubMed:12482977, PubMed:32433991). Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis (PubMed:7990953, PubMed:8675564). May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P51843/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NR0B1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NR0B1","total_profiled":1310},"omim":[{"mim_id":"615549","title":"ARMADILLO REPEAT-CONTAINING PROTEIN 5; ARMC5","url":"https://www.omim.org/entry/615549"},{"mim_id":"614736","title":"GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4","url":"https://www.omim.org/entry/614736"},{"mim_id":"614732","title":"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE","url":"https://www.omim.org/entry/614732"},{"mim_id":"612965","title":"46,XY SEX REVERSAL 3; SRXY3","url":"https://www.omim.org/entry/612965"},{"mim_id":"609300","title":"CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1; CYP17A1","url":"https://www.omim.org/entry/609300"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Centriolar satellite","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"adrenal gland","ntpm":34.7},{"tissue":"testis","ntpm":19.7}],"url":"https://www.proteinatlas.org/search/NR0B1"},"hgnc":{"alias_symbol":["DAX1","AHCH"],"prev_symbol":["AHC","DSS"]},"alphafold":{"accession":"P51843","domains":[{"cath_id":"1.10.565.10","chopping":"250-313_355-470","consensus_level":"medium","plddt":89.4382,"start":250,"end":470}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51843","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51843-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51843-F1-predicted_aligned_error_v6.png","plddt_mean":59.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NR0B1","jax_strain_url":"https://www.jax.org/strain/search?query=NR0B1"},"sequence":{"accession":"P51843","fasta_url":"https://rest.uniprot.org/uniprotkb/P51843.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51843/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51843"}},"corpus_meta":[{"pmid":"22331082","id":"PMC_22331082","title":"Investigating intestinal inflammation in DSS-induced model of IBD.","date":"2012","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/22331082","citation_count":540,"is_preprint":false},{"pmid":"9486644","id":"PMC_9486644","title":"Dax1 antagonizes Sry action in mammalian sex determination.","date":"1998","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9486644","citation_count":396,"is_preprint":false},{"pmid":"9843206","id":"PMC_9843206","title":"Role of Ahch in gonadal development and gametogenesis.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9843206","citation_count":341,"is_preprint":false},{"pmid":"9384387","id":"PMC_9384387","title":"DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9384387","citation_count":337,"is_preprint":false},{"pmid":"8630494","id":"PMC_8630494","title":"Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function.","date":"1996","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8630494","citation_count":308,"is_preprint":false},{"pmid":"10704874","id":"PMC_10704874","title":"SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10704874","citation_count":205,"is_preprint":false},{"pmid":"17114343","id":"PMC_17114343","title":"NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.","date":"2006","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/17114343","citation_count":173,"is_preprint":false},{"pmid":"15464421","id":"PMC_15464421","title":"Molecular mechanisms of DAX1 action.","date":"2004","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15464421","citation_count":159,"is_preprint":false},{"pmid":"26303087","id":"PMC_26303087","title":"DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease.","date":"2015","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26303087","citation_count":156,"is_preprint":false},{"pmid":"24727542","id":"PMC_24727542","title":"Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization.","date":"2014","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24727542","citation_count":150,"is_preprint":false},{"pmid":"9751505","id":"PMC_9751505","title":"DAX-1 blocks steroid production at multiple levels.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9751505","citation_count":149,"is_preprint":false},{"pmid":"12679814","id":"PMC_12679814","title":"Dax1 is required for testis determination.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12679814","citation_count":129,"is_preprint":false},{"pmid":"11738790","id":"PMC_11738790","title":"Phenotypic spectrum of mutations in DAX-1 and SF-1.","date":"2001","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11738790","citation_count":105,"is_preprint":false},{"pmid":"24232001","id":"PMC_24232001","title":"Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway.","date":"2013","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24232001","citation_count":104,"is_preprint":false},{"pmid":"32858892","id":"PMC_32858892","title":"Cow and Human Milk-Derived Exosomes Ameliorate Colitis in DSS Murine Model.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32858892","citation_count":100,"is_preprint":false},{"pmid":"10848616","id":"PMC_10848616","title":"Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10848616","citation_count":99,"is_preprint":false},{"pmid":"19188450","id":"PMC_19188450","title":"Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19188450","citation_count":91,"is_preprint":false},{"pmid":"10675033","id":"PMC_10675033","title":"Temperature-dependent sex determination in the American alligator: expression of SF1, WT1 and DAX1 during gonadogenesis.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10675033","citation_count":87,"is_preprint":false},{"pmid":"23861820","id":"PMC_23861820","title":"Dietary selenium deficiency exacerbates DSS-induced epithelial injury and AOM/DSS-induced tumorigenesis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23861820","citation_count":83,"is_preprint":false},{"pmid":"16466956","id":"PMC_16466956","title":"Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis.","date":"2006","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16466956","citation_count":82,"is_preprint":false},{"pmid":"11748841","id":"PMC_11748841","title":"Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenita.","date":"2001","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11748841","citation_count":77,"is_preprint":false},{"pmid":"19920188","id":"PMC_19920188","title":"EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19920188","citation_count":76,"is_preprint":false},{"pmid":"26464492","id":"PMC_26464492","title":"CRISPR/Cas9-mediated Dax1 knockout in the monkey recapitulates human AHC-HH.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26464492","citation_count":68,"is_preprint":false},{"pmid":"32802257","id":"PMC_32802257","title":"Melatonin Alleviates Neuroinflammation and Metabolic Disorder in DSS-Induced Depression Rats.","date":"2020","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/32802257","citation_count":68,"is_preprint":false},{"pmid":"15829514","id":"PMC_15829514","title":"Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15829514","citation_count":67,"is_preprint":false},{"pmid":"16206264","id":"PMC_16206264","title":"The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16206264","citation_count":66,"is_preprint":false},{"pmid":"16146703","id":"PMC_16146703","title":"DAX1 origin, function, and novel role.","date":"2005","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16146703","citation_count":61,"is_preprint":false},{"pmid":"35114907","id":"PMC_35114907","title":"Atractylodes lancea Rhizoma Attenuates DSS-Induced Colitis by Regulating Intestinal Flora and Metabolites.","date":"2022","source":"The American journal of Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35114907","citation_count":57,"is_preprint":false},{"pmid":"29497051","id":"PMC_29497051","title":"DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29497051","citation_count":56,"is_preprint":false},{"pmid":"12213901","id":"PMC_12213901","title":"WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells.","date":"2002","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12213901","citation_count":55,"is_preprint":false},{"pmid":"10599708","id":"PMC_10599708","title":"Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay.","date":"1999","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10599708","citation_count":55,"is_preprint":false},{"pmid":"21672607","id":"PMC_21672607","title":"Hypogonadotropic hypogonadism in subjects with DAX1 mutations.","date":"2011","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21672607","citation_count":54,"is_preprint":false},{"pmid":"15046740","id":"PMC_15046740","title":"Sex determination: a 'window' of DAX1 activity.","date":"2004","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/15046740","citation_count":53,"is_preprint":false},{"pmid":"29207040","id":"PMC_29207040","title":"Aryl hydrocarbon receptor inhibits inflammation in DSS‑induced colitis via the MK2/p‑MK2/TTP pathway.","date":"2017","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29207040","citation_count":53,"is_preprint":false},{"pmid":"17210221","id":"PMC_17210221","title":"DAX1: Increasing complexity in the roles of this novel nuclear receptor.","date":"2007","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17210221","citation_count":51,"is_preprint":false},{"pmid":"25284313","id":"PMC_25284313","title":"Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25284313","citation_count":50,"is_preprint":false},{"pmid":"17342735","id":"PMC_17342735","title":"Dax1 suppresses P450arom expression in medaka ovarian follicles.","date":"2007","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/17342735","citation_count":50,"is_preprint":false},{"pmid":"10656994","id":"PMC_10656994","title":"Cloning and expression of a DAX1 homologue in the chicken embryo.","date":"2000","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10656994","citation_count":49,"is_preprint":false},{"pmid":"24803164","id":"PMC_24803164","title":"The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice.","date":"2014","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24803164","citation_count":49,"is_preprint":false},{"pmid":"19508677","id":"PMC_19508677","title":"Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations.","date":"2009","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19508677","citation_count":48,"is_preprint":false},{"pmid":"12270141","id":"PMC_12270141","title":"Molecular cloning of DAX1 and SHP cDNAs and their expression patterns in the Nile tilapia, Oreochromis niloticus.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12270141","citation_count":48,"is_preprint":false},{"pmid":"33705951","id":"PMC_33705951","title":"Anthocyanin-containing purple potatoes ameliorate DSS-induced colitis in mice.","date":"2021","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33705951","citation_count":45,"is_preprint":false},{"pmid":"20943815","id":"PMC_20943815","title":"Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20943815","citation_count":44,"is_preprint":false},{"pmid":"11923472","id":"PMC_11923472","title":"Dax1 expression is dependent on steroidogenic factor 1 in the developing gonad.","date":"2002","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11923472","citation_count":42,"is_preprint":false},{"pmid":"39326132","id":"PMC_39326132","title":"Puerarin ameliorates colitis by direct suppression of macrophage M1 polarization in DSS mice.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39326132","citation_count":41,"is_preprint":false},{"pmid":"27709266","id":"PMC_27709266","title":"Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3.","date":"2016","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/27709266","citation_count":41,"is_preprint":false},{"pmid":"10412368","id":"PMC_10412368","title":"DAX-1, an 'antitestis' gene.","date":"1999","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/10412368","citation_count":39,"is_preprint":false},{"pmid":"17959853","id":"PMC_17959853","title":"The expression of nr0b1 and nr5a4 during gonad development and sex change in protandrous black porgy fish, Acanthopagrus schlegeli.","date":"2007","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/17959853","citation_count":39,"is_preprint":false},{"pmid":"11356697","id":"PMC_11356697","title":"Sertoli cell-specific rescue of fertility, but not testicular pathology, in Dax1 (Ahch)-deficient male mice.","date":"2001","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11356697","citation_count":38,"is_preprint":false},{"pmid":"14567960","id":"PMC_14567960","title":"DAX1 and its network partners: exploring complexity in development.","date":"2003","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14567960","citation_count":38,"is_preprint":false},{"pmid":"21164257","id":"PMC_21164257","title":"Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function.","date":"2010","source":"Endocrine development","url":"https://pubmed.ncbi.nlm.nih.gov/21164257","citation_count":37,"is_preprint":false},{"pmid":"14689056","id":"PMC_14689056","title":"Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients.","date":"2003","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/14689056","citation_count":37,"is_preprint":false},{"pmid":"27267667","id":"PMC_27267667","title":"nr0b1 (DAX1) mutation in zebrafish causes female-to-male sex reversal through abnormal gonadal proliferation and differentiation.","date":"2016","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27267667","citation_count":36,"is_preprint":false},{"pmid":"18406261","id":"PMC_18406261","title":"The Role of DAX-1 in Reproduction.","date":"1998","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/18406261","citation_count":36,"is_preprint":false},{"pmid":"35203241","id":"PMC_35203241","title":"Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35203241","citation_count":36,"is_preprint":false},{"pmid":"38330550","id":"PMC_38330550","title":"Macrophage Tim-3 maintains intestinal homeostasis in DSS-induced colitis by suppressing neutrophil necroptosis.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38330550","citation_count":34,"is_preprint":false},{"pmid":"16840536","id":"PMC_16840536","title":"Zebrafish dax1 is required for development of the interrenal organ, the adrenal cortex equivalent.","date":"2006","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16840536","citation_count":34,"is_preprint":false},{"pmid":"25772165","id":"PMC_25772165","title":"Nr0b1 is a negative regulator of Zscan4c in mouse embryonic stem cells.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25772165","citation_count":34,"is_preprint":false},{"pmid":"10341858","id":"PMC_10341858","title":"Novel DAX1 mutations in X-linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism.","date":"1999","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10341858","citation_count":34,"is_preprint":false},{"pmid":"25093581","id":"PMC_25093581","title":"Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25093581","citation_count":32,"is_preprint":false},{"pmid":"16645015","id":"PMC_16645015","title":"DAX1 and X-linked adrenal hypoplasia congenita: clinical and molecular analysis in five patients.","date":"2006","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16645015","citation_count":31,"is_preprint":false},{"pmid":"14678822","id":"PMC_14678822","title":"Nr0b1 and its network partners are expressed early in murine embryos prior to steroidogenic axis organogenesis.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/14678822","citation_count":30,"is_preprint":false},{"pmid":"23508100","id":"PMC_23508100","title":"Dax1 associates with Esrrb and regulates its function in embryonic stem cells.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23508100","citation_count":30,"is_preprint":false},{"pmid":"19644015","id":"PMC_19644015","title":"Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19644015","citation_count":30,"is_preprint":false},{"pmid":"30321511","id":"PMC_30321511","title":"Inhibition of NADPH oxidase activities ameliorates DSS-induced colitis.","date":"2018","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30321511","citation_count":28,"is_preprint":false},{"pmid":"16709599","id":"PMC_16709599","title":"Dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX1) (NR0B1) and small heterodimer partner (SHP) (NR0B2) form homodimers individually, as well as DAX1-SHP heterodimers.","date":"2006","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16709599","citation_count":28,"is_preprint":false},{"pmid":"12606353","id":"PMC_12606353","title":"Leydig cell-specific expression of DAX1 improves fertility of the Dax1-deficient mouse.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12606353","citation_count":27,"is_preprint":false},{"pmid":"20937355","id":"PMC_20937355","title":"LRH-1 and Nanog regulate Dax1 transcription in mouse embryonic stem cells.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20937355","citation_count":27,"is_preprint":false},{"pmid":"25966111","id":"PMC_25966111","title":"Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25966111","citation_count":27,"is_preprint":false},{"pmid":"19726747","id":"PMC_19726747","title":"Retinoic acid-induced nNOS expression depends on a novel PI3K/Akt/DAX1 pathway in human TGW-nu-I neuroblastoma cells.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19726747","citation_count":26,"is_preprint":false},{"pmid":"20055716","id":"PMC_20055716","title":"Targeting DAX-1 in embryonic stem cells and cancer.","date":"2010","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/20055716","citation_count":25,"is_preprint":false},{"pmid":"35669778","id":"PMC_35669778","title":"Gpr174 Knockout Alleviates DSS-Induced Colitis via Regulating the Immune Function of Dendritic Cells.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35669778","citation_count":24,"is_preprint":false},{"pmid":"35659877","id":"PMC_35659877","title":"A TRIM66/DAX1/Dux axis suppresses the totipotent 2-cell-like state in murine embryonic stem cells.","date":"2022","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/35659877","citation_count":23,"is_preprint":false},{"pmid":"8921887","id":"PMC_8921887","title":"Ahch, the mouse homologue of DAX1: cloning, characterization and synteny with GyK, the glycerol kinase locus.","date":"1996","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8921887","citation_count":23,"is_preprint":false},{"pmid":"18827407","id":"PMC_18827407","title":"Nuclear receptor DAX1 in human prostate cancer: a novel independent biological modulator.","date":"2008","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/18827407","citation_count":23,"is_preprint":false},{"pmid":"37098758","id":"PMC_37098758","title":"Geniposidic acid attenuates DSS-induced colitis through inhibiting inflammation and regulating gut microbiota.","date":"2023","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/37098758","citation_count":23,"is_preprint":false},{"pmid":"32084696","id":"PMC_32084696","title":"miR-142-5p/DAX1-dependent regulation of P450c17 contributes to triclosan-mediated testosterone suppression.","date":"2020","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/32084696","citation_count":22,"is_preprint":false},{"pmid":"15589120","id":"PMC_15589120","title":"NR0B1A: an alternatively spliced form of NR0B1.","date":"2004","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15589120","citation_count":22,"is_preprint":false},{"pmid":"30881446","id":"PMC_30881446","title":"Electroacupuncture and Moxibustion Improved Anxiety Behavior in DSS-Induced Colitis Mice.","date":"2019","source":"Gastroenterology research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/30881446","citation_count":21,"is_preprint":false},{"pmid":"39324491","id":"PMC_39324491","title":"FMT rescues mice from DSS-induced colitis in a STING-dependent manner.","date":"2024","source":"Gut microbes","url":"https://pubmed.ncbi.nlm.nih.gov/39324491","citation_count":20,"is_preprint":false},{"pmid":"11112659","id":"PMC_11112659","title":"Primate DAX1, SRY, and SOX9: evolutionary stratification of sex-determination pathway.","date":"2000","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11112659","citation_count":20,"is_preprint":false},{"pmid":"28893949","id":"PMC_28893949","title":"Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28893949","citation_count":20,"is_preprint":false},{"pmid":"16459121","id":"PMC_16459121","title":"A familial missense mutation in the hinge region of DAX1 associated with late-onset AHC in a prepubertal female.","date":"2006","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16459121","citation_count":19,"is_preprint":false},{"pmid":"9453240","id":"PMC_9453240","title":"Porcine Dax-1 gene: isolation and expression during gonadal development.","date":"1997","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9453240","citation_count":18,"is_preprint":false},{"pmid":"36580723","id":"PMC_36580723","title":"Dietary lactate supplementation can alleviate DSS-induced colitis in piglets.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36580723","citation_count":18,"is_preprint":false},{"pmid":"30738250","id":"PMC_30738250","title":"MLKL deficiency inhibits DSS-induced colitis independent of intestinal microbiota.","date":"2019","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30738250","citation_count":18,"is_preprint":false},{"pmid":"21240988","id":"PMC_21240988","title":"Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer.","date":"2011","source":"Journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21240988","citation_count":18,"is_preprint":false},{"pmid":"19773398","id":"PMC_19773398","title":"X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene.","date":"2009","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19773398","citation_count":17,"is_preprint":false},{"pmid":"38340032","id":"PMC_38340032","title":"Magnolin alleviated DSS-induced colitis by inhibiting ALOX5-mediated ferroptosis.","date":"2024","source":"The Kaohsiung journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38340032","citation_count":17,"is_preprint":false},{"pmid":"37054942","id":"PMC_37054942","title":"Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.","date":"2023","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37054942","citation_count":17,"is_preprint":false},{"pmid":"30442521","id":"PMC_30442521","title":"Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis.","date":"2018","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/30442521","citation_count":16,"is_preprint":false},{"pmid":"38601942","id":"PMC_38601942","title":"Lacticaseibacillusparacasei BNCC345679 revolutionizes DSS-induced colitis and modulates gut microbiota.","date":"2024","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/38601942","citation_count":16,"is_preprint":false},{"pmid":"35766233","id":"PMC_35766233","title":"Polydatin alleviates DSS- and TNBS-induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3.","date":"2022","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/35766233","citation_count":16,"is_preprint":false},{"pmid":"15841486","id":"PMC_15841486","title":"Thirteen novel mutations in the NR0B1 (DAX1) gene as cause of adrenal hypoplasia congenita.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15841486","citation_count":15,"is_preprint":false},{"pmid":"36084127","id":"PMC_36084127","title":"Cysteine protease of Clonorchis sinensis alleviates DSS-induced colitis in mice.","date":"2022","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36084127","citation_count":15,"is_preprint":false},{"pmid":"36016685","id":"PMC_36016685","title":"Baicalin Ameliorates DSS-Induced Colitis by Protecting Goblet Cells through Activating NLRP6 Inflammasomes.","date":"2022","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/36016685","citation_count":15,"is_preprint":false},{"pmid":"17686645","id":"PMC_17686645","title":"LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization.","date":"2007","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17686645","citation_count":14,"is_preprint":false},{"pmid":"25758177","id":"PMC_25758177","title":"Molecular cloning and sexually dimorphic expression patterns of nr0b1 and nr5a2 in olive flounder, Paralichthys olivaceus.","date":"2015","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/25758177","citation_count":14,"is_preprint":false},{"pmid":"37298283","id":"PMC_37298283","title":"Investigation of Flavonoid Scaffolds as DAX1 Inhibitors against Ewing Sarcoma through Pharmacoinformatic and Dynamic Simulation Studies.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37298283","citation_count":14,"is_preprint":false},{"pmid":"24742989","id":"PMC_24742989","title":"Ron receptor signaling is protective against DSS-induced colitis in mice.","date":"2014","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24742989","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50801,"output_tokens":7696,"usd":0.133921,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17093,"output_tokens":6502,"usd":0.124008,"stage2_stop_reason":"end_turn"},"total_usd":0.257929,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"DAX-1 binds DNA hairpin structures and acts as a transcriptional repressor of the StAR (steroidogenic acute regulatory protein) gene promoter, blocking steroid production in vitro and in vivo. DAX-1 binding sites were identified in the promoters of the dax-1 and StAR genes.\",\n      \"method\": \"In vitro DNA binding assays, transcriptional reporter assays (in vitro and in vivo), promoter analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro and in vivo assays with specific DNA binding and transcriptional repression demonstrated in multiple systems\",\n      \"pmids\": [\"9384387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"DAX-1 blocks steroid production at multiple levels by repressing StAR, P450scc, and 3beta-HSD promoter activities in adrenocortical Y-1 cells, impairing both basal and cAMP-stimulated steroid production without affecting the PKA pathway.\",\n      \"method\": \"Cell line expression (Y-1 cells), steroid production assays, promoter activity assays, cAMP pathway analysis\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple target genes tested with promoter assays and functional steroid production measurements in a defined cell system\",\n      \"pmids\": [\"9751505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Dax1 antagonizes Sry action in mammalian sex determination; XY mice carrying extra copies of Dax1 show delayed testis development, and sex reversal occurs when the transgene is tested against weak Sry alleles, establishing a dosage-sensitive genetic epistasis between Dax1 and Sry.\",\n      \"method\": \"Transgenic mouse overexpression, genetic epistasis with weak Sry alleles\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis in transgenic mouse model with defined allelic combinations, replicated across multiple Sry backgrounds\",\n      \"pmids\": [\"9486644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Loss of Ahch/Dax1 in male mice causes progressive degeneration of the testicular germinal epithelium and male sterility independent of abnormalities in gonadotropin and testosterone production, establishing Dax1 as essential for spermatogenesis maintenance. Female Ahch-null mice have normal ovarian development and fertility.\",\n      \"method\": \"Cre-mediated conditional gene knockout in mice, histological analysis, hormone measurement\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean loss-of-function mouse model with specific phenotypic readout and hormonal controls\",\n      \"pmids\": [\"9843206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DAX-1 protein is found both in the nucleus and cytoplasm; a significant proportion associates with polyribosomes and binds polyadenylated RNA. Two domains within DAX-1 mediate cooperative RNA binding. AHC-causing mutations significantly impair RNA binding, suggesting a post-transcriptional regulatory role.\",\n      \"method\": \"Subcellular fractionation, polyribosome sedimentation, RNA binding assays (direct), mutational analysis of AHC alleles\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct RNA binding demonstrated in vitro, subcellular fractionation, and mutational analysis linking RNA binding to disease; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"10848616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"AHC-associated DAX1 missense mutations abrogate its ability to act as a transcriptional repressor of SF-1, as demonstrated in transfection assays. All missense mutations are located within the carboxy-terminal half of the protein (putative ligand binding domain).\",\n      \"method\": \"Transfection reporter assays, mutational analysis of patient-derived alleles\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transfection assays with multiple disease mutations, single lab\",\n      \"pmids\": [\"11738790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sertoli cell-specific expression of a human DAX1 transgene (MIS promoter) partially rescued fertility in Dax1-deficient male mice, restoring sperm motility, epididymal sperm count, and in vitro fertilization capacity, establishing that Dax1 function in Sertoli cells is sufficient to overcome key thresholds for sperm production.\",\n      \"method\": \"Transgenic rescue in Dax1-knockout mice with cell type-specific promoter, fertility assays, sperm function assays\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific transgenic rescue with multiple functional readouts in defined genetic background\",\n      \"pmids\": [\"11356697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DAX-1 inhibits cAMP/SF-1-mediated aromatase P450 (P450arom) promoter activity in a dose-dependent manner in cultured human endometriotic and endometrial stromal cells; site-directed disruption of the SF-1 binding site in the P450arom promoter abolishes this effect, indicating DAX-1 acts through the SF-1 binding site.\",\n      \"method\": \"Transient transfection reporter assays, site-directed mutagenesis of promoter, human primary cell cultures\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with mutagenesis in primary human cells, single lab\",\n      \"pmids\": [\"12213901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Dax1 expression in the developing gonad is regulated by steroidogenic factor 1 (SF-1) via a conserved SF-1 consensus-binding site located ~4 kb upstream of the Dax1 start codon; Dax1 expression is greatly reduced in SF-1-deficient gonads.\",\n      \"method\": \"Transgenic reporter (LacZ) mouse assay, site-directed mutagenesis of SF-1 binding site, analysis of SF-1-null embryos\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic reporter with binding site mutagenesis and genetic knockout validation\",\n      \"pmids\": [\"11923472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Leydig cell-specific expression of DAX1 (LHR promoter transgene) in Dax1-knockout mice restores aromatase expression to normal levels and increases sperm production, establishing that Dax1 function in Leydig cells contributes to testicular function and that Dax1 deficiency in Leydig cells underlies aromatase overexpression.\",\n      \"method\": \"Transgenic rescue with Leydig cell-specific promoter in Dax1-knockout background, aromatase expression analysis, sperm counting\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific transgenic rescue with defined molecular and phenotypic endpoints\",\n      \"pmids\": [\"12606353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Nr0b1/Dax1 is required for testis differentiation; loss of Nr0b1 in mice impairs rather than promotes testis formation, contradicting the earlier 'anti-testis' model and instead supporting a pro-testis role.\",\n      \"method\": \"Targeted gene knockout in mice, gonadal development analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean loss-of-function mouse model with definitive developmental phenotype\",\n      \"pmids\": [\"12679814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In the developing testis, Sf1 and Dax1 function cooperatively (not antagonistically) to induce Dhh and Amh expression in Sertoli cells; double mutant Sf1/Dax1 gonads show reduced Dhh undetectable by E11.5, more severe than either single mutant, while Cyp17 and Cyp11a1 (fetal Leydig markers) are further reduced in double mutants compared to Sf1 heterozygotes alone.\",\n      \"method\": \"Genetic epistasis using compound mutant mice (Sf1 heterozygous × Dax1-null), gene expression analysis at defined embryonic stages\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — well-controlled genetic epistasis with multiple gene expression readouts at multiple time points\",\n      \"pmids\": [\"15829514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NR0B1 expression is required for the oncogenic/transformed phenotype of Ewing's sarcoma cells; retroviral-mediated RNAi knockdown of NR0B1 in patient-derived Ewing's sarcoma cell lines abolishes the transformed phenotype. NR0B1 is the most reproducibly upregulated EWS/FLI target gene across three Ewing's sarcoma lines.\",\n      \"method\": \"Retroviral RNAi knockdown in patient-derived cell lines, transcriptional profiling, functional transformation assays\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi knockdown with functional oncogenic phenotype readout in three independent patient-derived cell lines\",\n      \"pmids\": [\"17114343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DAX1 (NR0B1) is specifically upregulated by the EWS/FLI1 fusion oncoprotein (not by wild-type FLI1) in 293 cells and Ewing tumor cells; siRNA silencing of EWS/FLI1 in a Ewing cell line markedly reduces DAX1 mRNA and protein, confirming direct dependence on EWS/FLI1.\",\n      \"method\": \"cDNA arrays with inducible EWS/FLI1 expression, RNAi silencing, RT-PCR, immunoblot\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible expression and RNAi knockdown in two independent cell systems, confirmed at mRNA and protein level\",\n      \"pmids\": [\"16206264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Zebrafish dax1 functions downstream of ff1b (SF-1) in regulating the interrenal organ (adrenal cortex equivalent); dax1 morpholino knockdown downregulates steroidogenic genes cyp11a and star, and ff1b morpholino abolishes dax1 expression in the interrenal organ, while dax1 morpholino does not affect ff1b expression.\",\n      \"method\": \"Morpholino oligonucleotide knockdown in zebrafish, whole-mount in situ hybridization, gene expression analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via morpholino in zebrafish with defined expression readouts, single lab\",\n      \"pmids\": [\"16840536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DAX1 forms homodimers in both nucleus and cytoplasm; homodimerization involves an interaction between DAX1 amino and carboxy termini through LXXLL motifs and the AF-2 domain. DAX1 homodimers dissociate upon heterodimerization with SF-1 or ligand-activated ERα. DAX1-SHP heterodimers also form in the nucleus via LXXLL motifs and AF-2 domain.\",\n      \"method\": \"Co-immunoprecipitation in mammalian cells, subcellular localization studies, domain-deletion and mutagenesis analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mutagenesis, single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"16709599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Dax1 has a novel role in maintaining a relatively undifferentiated state in early embryogenesis; siRNA knockdown of Nr0b1 in embryonic stem cells causes differentiation toward endoderm-like fate, and conditional knockout of Nr0b1 in ES cells leads to differentiation, indicating Nr0b1 maintains pluripotency independent of steroidogenesis.\",\n      \"method\": \"siRNA knockdown in ES cells, Cre-mediated conditional knockout in ES cells, differentiation assays\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown and knockout with differentiation readouts, single lab, two orthogonal loss-of-function approaches\",\n      \"pmids\": [\"16466956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dax-1 can function as a dosage-dependent coactivator of SF-1 target genes (rather than solely as a repressor). Both SF-1 and Dax-1 bind the RNA coactivator SRA; TIF2 associates with Dax-1 and synergistically coactivates SF-1 targets. Knockdown of endogenous Dax-1 downregulates CYP11A1 and StAR expression in adrenal and Leydig cells. A naturally occurring Dax-1 mutation inhibits this coactivation and mislocalizes the Dax-1/TIF2 complex.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assays, siRNA knockdown of SRA and Dax-1, live-cell imaging of protein localization, patient mutation analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, reporter, RNAi, localization) in multiple cell types with disease mutation validation\",\n      \"pmids\": [\"19188450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NR0B1 and EWS/FLI physically interact; this protein-protein interaction is required for oncogenic transformation of Ewing's sarcoma cells. NR0B1 mutations that disrupt the interaction have transcriptional consequences and abrogate oncogenic transformation. Genome-wide ChIP shows NR0B1 and EWS/FLI co-localize at overlapping genomic targets.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), transcriptional profiling, transformation assays with NR0B1 interaction-defective mutants\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, ChIP-seq co-localization, and functional mutant rescue across multiple endpoints\",\n      \"pmids\": [\"19920188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DAX1 (NR0B1) is expressed in cancer stem cell-enriched side population of lung adenocarcinoma; NR0B1 knockdown reduces invasion, colony formation, and tumorigenicity in NOD/SCID mice, establishing a functional role in lung adenocarcinoma malignancy.\",\n      \"method\": \"Hoechst dye exclusion (side population assay), RNAi knockdown, in vitro invasion and colony assays, xenograft tumorigenicity assay\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown with multiple functional oncogenic readouts including in vivo xenograft, single lab\",\n      \"pmids\": [\"19644015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In mouse ES cells, Dax1 forms a complex with LRH-1 (Nr5a2) demonstrated by co-immunoprecipitation. Contrary to its repressor role in steroidogenic cells, Dax1 accentuates LRH-1-mediated activation of the Oct4 gene; Dax1 is localized to the Oct4 promoter at the LRH-1 binding site by ChIP. This coactivation is dependent on the RNA coactivator SRA.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), luciferase reporter assays with Dax1 overexpression/knockdown, SRA knockdown\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, ChIP, reporter, RNAi) in mES cells establishing coactivation mechanism\",\n      \"pmids\": [\"20943815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"LRH-1 binds the -128 site of the Dax1 promoter to regulate its expression in mouse ES cells; Nanog binds an intronic site of Dax1 and enhances transcription. Overexpression and knockdown of both LRH-1 and Nanog alter Dax1 expression, establishing cooperative transcriptional regulation of Dax1 in ES cells.\",\n      \"method\": \"Luciferase reporter assays, EMSA, chromatin immunoprecipitation, overexpression and knockdown experiments\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (EMSA, ChIP, reporter, OE/KD) in a single lab\",\n      \"pmids\": [\"20937355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dax1 interacts with the orphan nuclear receptor Esrrb through DAX1 LXXLL motifs and Esrrb activation/ligand-binding domains. Dax1 represses Esrrb transcriptional activity. Esrrb also directly binds the Dax1 promoter (ERRE1 site) to enhance Dax1 expression in an Oct3/4-independent manner. Oct3/4, Dax1, and Esrrb exhibit competitive inhibitory interactions forming a regulatory loop.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assays, EMSA/direct binding assays, overexpression and knockdown in ES cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mapping and reporter assays, single lab\",\n      \"pmids\": [\"23508100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dax1 acts in parallel with Nanog to maintain mouse ES cell identity; Dax1 overexpression supports LIF-independent self-renewal; Dax1 stable knockdown predisposes mESCs towards differentiation. Dax1 is indispensable for self-renewal of Nanog-low mESCs. Dax1 prevents extra-embryonic endoderm commitment by directly repressing Gata6 transcription.\",\n      \"method\": \"Stable knockdown, overexpression, inducible knockdown, LIF-withdrawal assay, luciferase/reporter assays for Gata6 repression, reprogramming assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple loss-of-function and gain-of-function approaches with specific cellular and molecular readouts; direct promoter repression shown\",\n      \"pmids\": [\"25284313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nr0b1 (Dax1)-null mouse ES cells are viable and pluripotent but exhibit slow proliferation and overexpression of 2-cell-stage transcripts including Zscan4c. Nr0b1 directly represses the Zscan4c promoter; overexpression of Zscan4c causes G2 arrest and cell death, explaining the proliferation defect.\",\n      \"method\": \"Inducible Cre-loxP knockout in ES cells, chimera assay for pluripotency, transcriptome analysis, direct promoter repression assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible knockout with defined molecular mechanism (direct promoter repression), single lab\",\n      \"pmids\": [\"25772165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"nr0b1 mutation in zebrafish causes female-to-male sex reversal through reduced cell proliferation and abnormal somatic cell differentiation in gonads at the undifferentiated and bi-potential ovary stages, without increasing apoptosis (Caspase-3, tp53-independent mechanism).\",\n      \"method\": \"CRISPR/ENU-generated heritable nr0b1 mutations in zebrafish, histological analysis, cell proliferation assays, genetic epistasis with tp53 mutation\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — heritable loss-of-function with cellular mechanism defined, genetic epistasis performed, single lab\",\n      \"pmids\": [\"27267667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sf1 SUMOylation enhances binding of Dax1 to Sf1, which further enhances transcriptional repression of the fetal adrenal enhancer (FAdE). In vivo, both SUMOylation-deficient Sf1 and Dax1-knockout mice show delayed regression of the postnatal fetal adrenal cortex (X-zone), with FAdE expression retained in postnatal X-zone cells.\",\n      \"method\": \"In vitro binding assays, transgenic reporter mouse models (FAdE-LacZ), Sf1 SUMOylation-deficient knock-in mice, Dax1-knockout mice\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro binding assay with multiple in vivo mouse models demonstrating convergent repressor function\",\n      \"pmids\": [\"28893949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DAX1 promotes cervical cancer cell growth and tumorigenicity by transcriptionally repressing GSK3β (an inhibitor of Wnt/β-catenin) through direct binding to the -666~-444 region of the GSK3β promoter, as confirmed by dual-luciferase reporter and ChIP assays, leading to activation of Wnt/β-catenin signaling and upregulation of cyclinD1 and c-myc.\",\n      \"method\": \"RNAi knockdown, TOP/FOP-Flash Wnt reporter assay, ChIP assay, dual-luciferase reporter assay, GSK3β pharmacological rescue\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays define direct promoter binding, functional rescue confirms mechanism, single lab\",\n      \"pmids\": [\"29497051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TRIM66 recruits DAX1 as a co-repressor to the Dux promoter to suppress the totipotent 2-cell-like state in mESCs. TRIM66's repressive effect on Dux is dependent on DAX1. Crystal structure shows TRIM66's PHD finger recognizes H3K4-K9me3; mutations in the PHD finger abolish Dux repression.\",\n      \"method\": \"Co-IP, ChIP, crystal structure determination, mutagenesis of PHD finger, chimeric embryo assays, Dux reporter assays\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with co-IP, ChIP, and functional mutagenesis in a single rigorous study\",\n      \"pmids\": [\"35659877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A missense mutation in the hinge region of DAX1 (C200W) shifts subcellular localization from nucleus to cytoplasm and impairs transcriptional repression activity. Nuclear import of DAX1 involves a direct interaction with SF-1; the C200W mutant retains ability to interact with SF-1 in vitro, suggesting SF-1-independent interactions are responsible for the import defect.\",\n      \"method\": \"Immunohistochemistry of transfected cells, transcriptional repression assays, in vitro interaction assays\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — subcellular localization tied to functional repression defect, in vitro interaction assay, single lab\",\n      \"pmids\": [\"16459121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Retinoic acid (RA)-induced nNOS transcription in human neuroblastoma TGW-nu-I cells requires DAX1 (NR0B1) as a critical mediator; RA increases DAX1 expression via PI3K/Akt signaling, and upregulation of DAX1 in turn induces nNOS transcription. DAX1 knockdown blocks RA-induced nNOS expression, identifying nNOS as a DAX1 target gene in this pathway.\",\n      \"method\": \"Pharmacological inhibition of PI3K/Akt, DAX1 overexpression and knockdown, transcriptional reporter/RT-PCR assays in human neuroblastoma cells\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown and overexpression with pathway inhibitors in a defined cellular context, single lab\",\n      \"pmids\": [\"19726747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LXXLL motifs and AF-2 domain of SHP mediate SHP homodimerization and DAX1-SHP heterodimerization. DAX1 LXXLL motifs are redundant for DAX1 homodimerization. DAX1A (alternatively spliced isoform) localizes predominantly to cytoplasm but forms DAX1-DAX1A heterodimers in the nucleus, with AF-2 domain of DAX1 required for this interaction.\",\n      \"method\": \"Co-immunoprecipitation, domain deletion and mutagenesis, subcellular localization analysis\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mutagenesis, single lab, extends prior homodimerization findings\",\n      \"pmids\": [\"17686645\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NR0B1/DAX1 is an atypical orphan nuclear receptor that functions context-dependently as a transcriptional repressor or coactivator: it represses steroidogenic gene promoters (StAR, P450scc, 3β-HSD, aromatase) by binding DNA hairpin structures and/or inhibiting SF-1/LRH-1-mediated transactivation, forms homo- and heterodimers (with SHP, DAX1A) via LXXLL motifs and an AF-2 domain, shuttles between nucleus and cytoplasm where it also binds polyribosomal mRNA, and can coactivate SF-1/LRH-1 target genes (including Oct4) through the RNA coactivator SRA and TIF2; in ES cells it directly represses Gata6 and Zscan4c to maintain pluripotency, and in Ewing's sarcoma it physically interacts with the EWS/FLI oncoprotein to co-regulate transcription and drive oncogenic transformation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NR0B1/DAX1 is an atypical orphan nuclear receptor that operates as a context-dependent transcriptional regulator coordinating steroidogenesis, gonadal development, and stem cell pluripotency [#0, #16]. In steroidogenic tissues it represses the promoters of StAR, P450scc, 3beta-HSD, and aromatase, blocking both basal and cAMP-stimulated steroid output, largely by binding DNA hairpin structures and antagonizing SF-1 at SF-1 response elements [#0, #1, #7]; this repressor function is abolished by AHC-associated missense mutations clustered in the carboxy-terminal ligand-binding domain [#5]. DAX1 self-associates and partners with other receptors—forming homodimers and DAX1-SHP and DAX1-DAX1A heterodimers through its LXXLL motifs and AF-2 domain, with homodimers dissociating upon engagement of SF-1 or ligand-activated ERalpha [#15, #31]. Rather than acting purely as a repressor, DAX1 can also coactivate SF-1 and LRH-1 target genes through the RNA coactivator SRA and the cofactor TIF2, and its own expression is reciprocally driven by SF-1, LRH-1, Nanog, and Esrrb [#17, #20, #8, #21]. DAX1 expression and activity are tightly dosage-sensitive in gonadal development: it cooperates with SF-1 to induce Sertoli-cell genes (Dhh, Amh) and is required in both Sertoli and Leydig cells for spermatogenesis and proper aromatase control [#11, #6, #9], and its loss impairs testis differentiation [#10]. In embryonic stem cells DAX1 maintains pluripotency independently of steroidogenesis by directly repressing the endoderm regulator Gata6 and the 2-cell-stage gene Zscan4c, and it serves as a TRIM66-recruited co-repressor of Dux to suppress the totipotent 2-cell-like state [#23, #24, #28]. DAX1 also functions oncogenically: it is the most reproducible EWS/FLI1 target in Ewing's sarcoma, where a direct NR0B1–EWS/FLI protein interaction is required for transformation and co-occupies overlapping genomic targets [#13, #12, #18]. A significant pool of DAX1 resides in the cytoplasm associated with polyribosomes and polyadenylated RNA, a post-transcriptional activity also impaired by AHC mutations [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established the core molecular activity of DAX1 by showing it is a sequence-specific transcriptional repressor of steroidogenic genes, defining its biochemical identity beyond an orphan receptor.\",\n      \"evidence\": \"In vitro DNA binding and reporter assays on the StAR and dax-1 promoters\",\n      \"pmids\": [\"9384387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DNA hairpin recognition not structurally resolved\", \"no endogenous genome-wide binding map\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the breadth of DAX1's anti-steroidogenic action and its dosage-sensitive antagonism of male sex determination, framing DAX1 as a brake on steroid output and an 'anti-testis' factor.\",\n      \"evidence\": \"Promoter and steroid-production assays in Y-1 cells; transgenic mouse epistasis against weak Sry alleles\",\n      \"pmids\": [\"9751505\", \"9486644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"repressor mechanism on multiple promoters not distinguished (direct DNA vs SF-1 antagonism)\", \"the anti-testis model later revised\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Loss-of-function in mice revealed DAX1 is essential for spermatogenesis maintenance independent of hormonal output, separating a tissue role from its endocrine repressor function.\",\n      \"evidence\": \"Conditional knockout in mice with histology and hormone measurement\",\n      \"pmids\": [\"9843206\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"cell type responsible not yet localized\", \"molecular targets in germinal epithelium unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovered a non-transcriptional facet of DAX1—cytoplasmic polyribosome and RNA binding—linking it to post-transcriptional regulation and tying this activity to disease alleles.\",\n      \"evidence\": \"Subcellular fractionation, polyribosome sedimentation, direct RNA binding and AHC mutant analysis\",\n      \"pmids\": [\"10848616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"specific mRNA targets not identified\", \"physiological consequence of RNA binding unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Connected AHC-causing missense mutations to loss of SF-1 repression and mapped them to the C-terminal LBD, establishing a genotype-to-mechanism link for the disease.\",\n      \"evidence\": \"Transfection reporter assays of patient-derived alleles\",\n      \"pmids\": [\"11738790\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single-lab transfection data\", \"no structural basis for LBD mutation effects\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Cell-type-specific transgenic rescue localized a key reproductive function of DAX1 to Sertoli cells, refining where its activity is required.\",\n      \"evidence\": \"MIS-promoter human DAX1 transgene rescue in Dax1-null mice with fertility/sperm assays\",\n      \"pmids\": [\"11356697\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"rescue only partial\", \"molecular targets in Sertoli cells not defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed DAX1 represses aromatase via the SF-1 binding site and that SF-1 drives Dax1 expression, establishing a reciprocal SF-1/DAX1 regulatory relationship.\",\n      \"evidence\": \"Promoter mutagenesis/reporter assays in human stromal cells; transgenic LacZ reporter and SF-1-null embryo analysis\",\n      \"pmids\": [\"12213901\", \"11923472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether repression requires direct DAX1-DNA contact or only SF-1 tethering unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Genetic and rescue studies revised the sex-determination model, showing DAX1 promotes rather than opposes testis differentiation and acts in Leydig cells to control aromatase.\",\n      \"evidence\": \"Targeted knockout gonad analysis; LHR-promoter Leydig-specific transgenic rescue\",\n      \"pmids\": [\"12679814\", \"12606353\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanistic reconciliation of dosage 'anti-testis' overexpression with loss-of-function pro-testis role incomplete\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Compound-mutant epistasis demonstrated that DAX1 and SF-1 act cooperatively—not antagonistically—to induce Sertoli-cell genes, redefining their relationship in development.\",\n      \"evidence\": \"Sf1/Dax1 compound mutant mice with staged expression analysis of Dhh, Amh, Cyp17, Cyp11a1\",\n      \"pmids\": [\"15829514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct vs indirect cooperativity at target promoters not dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the structural basis of DAX1 dimerization and identified its self- and partner-association via LXXLL/AF-2 modules, explaining how dimer state couples to SF-1/ER engagement.\",\n      \"evidence\": \"Co-IP, domain mutagenesis, and localization studies of DAX1 homodimers and DAX1-SHP and DAX1-DAX1A heterodimers\",\n      \"pmids\": [\"16709599\", \"17686645\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single-lab co-IP without structure\", \"functional output of each dimer species not separated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Revealed a steroidogenesis-independent role in maintaining the undifferentiated state of ES cells, expanding DAX1's biology into pluripotency.\",\n      \"evidence\": \"siRNA and conditional knockout in ES cells with differentiation assays\",\n      \"pmids\": [\"16466956\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"direct target genes not yet identified at this stage\", \"single-lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapped a hinge-region mutation (C200W) that mislocalizes DAX1 to cytoplasm and abolishes repression, implicating SF-1-independent nuclear import in its activity.\",\n      \"evidence\": \"Immunohistochemistry, repression assays, and in vitro interaction assays of the C200W mutant\",\n      \"pmids\": [\"16459121\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"the import factor responsible not identified\", \"single-lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified NR0B1 as a critical, reproducibly upregulated EWS/FLI1 target required for the transformed phenotype in Ewing's sarcoma, opening an oncogenic dimension.\",\n      \"evidence\": \"Inducible EWS/FLI1 expression, RNAi silencing, and transformation assays across multiple Ewing cell lines\",\n      \"pmids\": [\"17114343\", \"16206264\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism of NR0B1 contribution to transformation not yet defined at this stage\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Cross-species work placed dax1 downstream of SF-1 (ff1b) in regulating the adrenal-equivalent interrenal organ and its steroidogenic genes.\",\n      \"evidence\": \"Morpholino knockdown and in situ hybridization in zebrafish\",\n      \"pmids\": [\"16840536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"morpholino specificity caveats\", \"single-lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Reframed DAX1 as a dosage-dependent coactivator, not just a repressor, by linking it to the RNA coactivator SRA and TIF2 to activate SF-1 targets.\",\n      \"evidence\": \"Co-IP, reporter assays, SRA/Dax-1 knockdown, live-cell imaging, and disease-mutation analysis in adrenal/Leydig cells\",\n      \"pmids\": [\"19188450\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"determinants switching DAX1 between repressor and coactivator modes unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established a direct NR0B1–EWS/FLI protein interaction required for transformation and showed genome-wide co-occupancy, providing the mechanistic link for DAX1's oncogenic role.\",\n      \"evidence\": \"Co-IP, ChIP, transcriptional profiling, and interaction-defective mutant rescue in Ewing cells\",\n      \"pmids\": [\"19920188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how the interaction reshapes EWS/FLI transcriptional output mechanistically not fully defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended DAX1's oncogenic relevance beyond Ewing's sarcoma to lung adenocarcinoma cancer-stem-cell function and to a neuronal RA/PI3K-Akt-nNOS axis, indicating broad context-specific roles.\",\n      \"evidence\": \"Side-population assay, RNAi, invasion/colony/xenograft assays in lung adenocarcinoma; pathway inhibition and knockdown/overexpression in neuroblastoma\",\n      \"pmids\": [\"19644015\", \"19726747\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"direct DAX1 targets in these contexts incompletely defined\", \"single-lab each\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated context-switched coactivation in ES cells, where DAX1 complexes with LRH-1 to activate Oct4 via SRA, and that LRH-1/Nanog reciprocally drive Dax1, embedding it in the pluripotency network.\",\n      \"evidence\": \"Co-IP, ChIP, EMSA, reporter assays, and SRA/factor knockdown in mouse ES cells\",\n      \"pmids\": [\"20943815\", \"20937355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"what dictates LRH-1 coactivation vs SF-1 repression unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Positioned DAX1 within a competitive regulatory loop with Esrrb and Oct3/4, repressing Esrrb activity while being reciprocally regulated, refining pluripotency circuit logic.\",\n      \"evidence\": \"Co-IP with domain mapping, EMSA, reporter assays, and OE/KD in ES cells\",\n      \"pmids\": [\"23508100\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single-lab\", \"in vivo relevance of the loop not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined a direct molecular mechanism for pluripotency maintenance—DAX1 represses Gata6 to block extra-embryonic endoderm—acting in parallel with Nanog.\",\n      \"evidence\": \"Stable/inducible knockdown, overexpression, LIF-withdrawal, Gata6 reporter, and reprogramming assays\",\n      \"pmids\": [\"25284313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"genome-wide direct target set not fully enumerated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified Zscan4c as a direct DAX1-repressed 2-cell-stage gene whose derepression causes proliferation defects, linking DAX1 to control of the totipotency program.\",\n      \"evidence\": \"Inducible knockout in ES cells, transcriptome analysis, and direct promoter repression assay\",\n      \"pmids\": [\"25772165\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single-lab\", \"relationship to other 2C regulators not fully mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed SF-1 SUMOylation enhances DAX1 recruitment to drive repression of the fetal adrenal enhancer, providing a PTM-controlled mechanism for fetal adrenal X-zone regression.\",\n      \"evidence\": \"In vitro binding, FAdE-LacZ reporter mice, SUMO-deficient Sf1 knock-in and Dax1-knockout mice\",\n      \"pmids\": [\"28893949\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how SUMOylation alters the SF-1/DAX1 interface structurally unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated a pro-oncogenic mechanism in cervical cancer where DAX1 directly represses GSK3beta to activate Wnt/beta-catenin signaling, expanding its tumor-promoting repertoire.\",\n      \"evidence\": \"RNAi, TOP/FOP-Flash Wnt reporter, ChIP, dual-luciferase, and GSK3beta rescue\",\n      \"pmids\": [\"29497051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single-lab\", \"in vivo confirmation limited\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided structural and functional mechanism for DAX1 as a TRIM66-recruited co-repressor of Dux, showing how it suppresses the totipotent 2-cell-like state via a chromatin-reading module.\",\n      \"evidence\": \"Co-IP, ChIP, crystal structure of TRIM66 PHD finger, PHD mutagenesis, and chimeric embryo/Dux reporter assays\",\n      \"pmids\": [\"35659877\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DAX1's own contribution to repressive complex assembly not structurally resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular determinant that switches DAX1 between transcriptional repressor and coactivator across steroidogenic, pluripotency, and oncogenic contexts remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"no structural model of DAX1 DNA/hairpin or coactivator binding\", \"the natural ligand (if any) and its role in mode-switching unknown\", \"no unified rule predicting repressor vs coactivator output by partner/context\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 7, 17, 20, 23, 24, 27]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 24, 27]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [17, 20, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 15, 29]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 15, 29, 31]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 7, 17, 20, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 3, 10, 11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [12, 18, 19, 27]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NR5A1\", \"NR5A2\", \"NR0B2\", \"ESRRB\", \"EWSR1-FLI1\", \"TIF2\", \"TRIM66\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}